Steven M. Paul, Director at Sage Therapeutics, Inc. (SAGE), sold 58,139 shares at $172.00 ($10.0M) on 2018-03-06, disclosed to the SEC on 2018-03-08.
Open-market sale of $10.0M SAGE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KRTX | BUY | 2021-08-18 | $501K | — | Filing → |
| ALNY | SELL | 2020-12-22 | $2.1M | — | Filing → |
| KRTX | SELL | 2020-06-30 | $60.5M | — | Filing → |